J Physiol (Paris) 1993
Early-phase clinical trials including a Phase 2 dose-ranging study published in the New England Journal of Medicine (2023) have demonstrated significant potential for weight reduction and metabolic improvement, generating considerable scientific interest
Goetjen, T.A., Liu, J., Wu, Y., Sui, J., Zhang, X., Hupp, J.T., Farha, O.K.: Metalorganic framework (MOF) materials as polymerization catalysts: a review and recent advances
Nevertheless, we recommend our clients to handle peptides with caution
Lidocaine promoted ferroptosis by targeting miR-382-5p /SLC7A11 axis in ovarian and breast cancer
However, their therapeutic outcomes are limited because of drug resistance due to the intracellular inactivation effect ( 2 complex with platinum drugs